Ticker

No recent analyst price targets found for CRTD.

Latest News for CRTD

Creatd Completes 1:20 Reverse Stock Split as Part of Uplisting Strategy

• No financing will accompany the reverse split • Reverse split necessary to meet national exchange listing requirements • Reverse split approved by the Company's Shareholders and Board of Directors NEW YORK, NY, February 23, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Creatd, Inc.

MCAP MediaWire • Feb 23, 2026
Creatd Completes 1:20 Reverse Stock Split as Part of Uplisting Strategy

No financing will accompany the reverse split Reverse split necessary to meet national exchange listing requirements Reverse split approved by the Company's Shareholders and Board of Directors NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTD) (“Creatd” or the “Company”) today announced that it will implement a 20:1 reverse stock split of its issued and outstanding common stock, effective…

GlobeNewsWire • Feb 23, 2026
VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.

New York, NY, Feb. 17, 2026, – PRISM MediaWire (Press Release Service – Press Release Distribution) – Creatd, Inc. (OTCQB: CRTD) announced that Catheter Precision, Inc. (NYSE American: VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder.

MCAP MediaWire • Feb 17, 2026
VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.

Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary. Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.

GlobeNewsWire • Feb 17, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CRTD.

No House trades found for CRTD.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top